John Treace News Today

With the earnings season winding down and windows for making insider purchases opening up, CEOs and other insiders have been scooping up shares.

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call Transcript February 28, 2024 Treace Medical Concepts, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Treace Medical Concepts Fourth […]

Operator: Good day, and thank you for standing by. Welcome to the Treace Medical Concepts Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator instructions].

Operator: Good day and thank you for standing by. Welcome to Treace Medical Concepts Third Quarter 2023 Earnings Conference Call.

CEO John Treace says the company’s Lapiplasty solution to the painful foot condition has only scratched the surface of a more than $5 billion market.

Analysts say the title insurer is managing well in a tough environment.

Operator: Good day and thank you for standing by. Welcome to the Treace Medical Concepts Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

The Fidelity National Financial spinoff is the largest D&B shareholder.

Tenant Contractors Inc. will handle the $2.34 million project at the four-story building, where the medical products company leases the first and top levels.

The Ponte Vedra-based company already occupies the first and top levels of the four-story building.